Neuro oncology drug trials in New York

Christian Grommes, MD is a renowned MSK Neurologist & Neuro-Oncologist at 1275 York Avenue in New York City, United States. This institution is dedicated to changing the way cancer is understood and treated, with a focus on early drug development. They offer specialized educational programs to train the next generation of cancer care leaders. Operating Monday through Friday from 8 a.m. to 6 p.m. Eastern time, they provide comprehensive care for all types of cancer. Dr. Grommes specializes in adult primary brain tumors and is actively involved in research to advance treatment options. With a multidisciplinary approach, their team ensures the best possible care for patients and their families. Additionally, they work on developing new cancer treatments through clinical trials and collaborations with various healthcare providers. Financial assistance programs are available for those without insurance coverage. Patients can explore clinical trial opportunities and access Dr. Grommes's research articles on PubMed. Transparency and patient trust are key values at this institution, with a commitment to disclosing any external relationships that may influence patient care. For more information on their policies and procedures, patients can contact MSK's Compliance Office.

Thomas J. Kaley, MD is a renowned institution located at 1275 York Avenue, New York, United States. Specializing in Neuro-Oncology and Early Drug Development, our team of experts is dedicated to changing the way cancer is understood and treated. From cutting-edge research to highly specialized educational programs, we are committed to shaping the future of cancer care. Our clinic operates Monday through Friday, providing comprehensive care for all types of cancer, including brain tumors and neurologic complications of cancer. Dr. Kaley and his team are at the forefront of clinical trials and research for various types of brain tumors, offering compassionate and effective care for patients. Additionally, we work with various insurance providers to ensure that patients receive the coverage they need. With a focus on transparency and patient care, we strive to provide the best possible treatment options for all individuals facing cancer.